December 2, 2022
GlaxoSmithKline Consumer Healthcare ULC is recalling one lot of TUMS Peppermint Regular Strength tablets after some tablets were found to contain fragments of fibreglass and other material, including paper and aluminum foil.
The product was distributed across Canada starting on October 25, 2022, and is sold in a package of three rolls containing 12 tablets each.
TUMS is an antacid indicated for adults that is intended to relieve indigestion and heartburn. If consumed, the fragments should pass through most people's digestive systems with no concern. However, elderly people and people with narrow areas in their intestines because of disease or surgery may be at risk of injury.
Health Canada is monitoring the recall and will update the public if any new risks are identified.
About the Author(s)
You May Also Like
1 Injured in Explosion at Industrial Adhesives & Coatings PlantDec 01, 2023
End-of-Year Chemical Industry OutlookDec 01, 2023
Post to Close Cereal Manufacturing FacilityDec 01, 2023
Child Labor Lawsuit Targets Major Food CompaniesDec 01, 2023